UT Southwestern Scientists Find Cell Death-Signaling Pathway Involved In Cancer

November 13, 1997

DALLAS -- November 14, 1997 -- The missing link in the chain of molecules that tells cells to die has been found, which may enable scientists to create more effective drugs for cancer, Parkinson's disease and stroke. The discovery by researchers at UT Southwestern Medical Center at Dallas is reported in the Nov. 14 issue of Cell.

The investigators used human breast-cancer cells and human cervical-cancer cells to identify and purify a protein they dubbed Apaf-3. The findings indicate Apaf-3 signals apoptosis, programmed cell death. From the Greek word for shedding leaves, apoptosis is the natural way the body eliminates unnecessary or damaged cells and makes room for new ones in the development, growth and maintenance of tissue in animals and plants. The process is necessary for life because some cells are constantly replenished; for instance, cells lining the human intestine live less than a week. Cardiac neurons and skeletal cells can't be replenished and must last a lifetime.

But if a mistake occurs in the signals sent to a cell -- because of a mutation in a gene, for instance -- normal cell death may not occur. Depending on how the message is scrambled, too many cells may live, or too many cells may die. If apoptosis doesn't occur, cancer or autoimmune diseases may develop. Neurological disorders, paralysis and/or death of the organism itself result when too many cells commit suicide.

"What we define in this paper is how cell death is executed through a cascade of events," said Dr. Xiaodong Wang, UT Southwestern assistant professor of biochemistry and Howard Hughes Medical Institute investigator. He and his research team published two other papers this year showing how various genes and other proteins fit into the pathway to apoptosis.

Scientists previously determined that they still needed to identify one protein in the sequence of events leading to apoptosis, Wang said. In the latest study, Wang found that two molecules, cytochrome c and dATP/ATP, bind to activate Apaf-3. This occurrence initiates the cascade of events leading to cell death. Cytochrome c is a regulatory protein released from the cell's principal energy source, the mitochondria. Adenosine triphosphate, ATP, carries energy from the mitochondria to all parts of a cell.

"We now know how cells commit suicide," Wang said. "We determined the pathway that is part of this fundamental biological process. This information can be used to find drugs to activate the pathway, especially in cancer cells. Most chemotherapy drugs work through the pathways, but they are not directed at the exact molecules triggering cell death."

This new knowledge gives scientists better targets for efforts to switch the cascade on and off. A better understanding of apoptosis also could lead to ways to prevent cell death as a result of strokes, myocardial infarction and many neurodegenerative diseases.

Others involved in the study from UT Southwestern were biochemistry research fellows Drs. Imawati Budihardjo and Peng Li; Deepak Nijhawan, a Medical Scientist Training Program fellow; and microbiology and immunology researchers from Thomas Jefferson University Drs. Srinivasa M. Srinivasula, Manzoor Ahmad and Emad S. Alnermri.

The research was funded in part by the American Cancer Society and the National Institutes of Health.
-end-


UT Southwestern Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.